Oncolytic Virus Therapy Market Regional Analysis and Competitive Landscape
The oncolytic virus therapy market exhibits distinct regional characteristics that reflect varying biotechnology maturity, regulatory frameworks, clinical trial infrastructure, and manufacturing capabilities. North America retained market leadership with 42.6% of global share in 2025, underpinned by the United States' dominant position in biotechnology innovation, with Amgen's T-VEC...
0 Commenti 0 condivisioni 2 Views 0 Anteprima